TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
1-Year Return
35.44%
This Quarter Return
+9.48%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$239M
AUM Growth
-$74.7M
(-24%)
Cap. Flow
-$89.9M
Cap. Flow
% of AUM
-37.63%
Top 10 Holdings %
Top 10 Hldgs %
77.92%
Holding
44
New
11
Increased
6
Reduced
8
Closed
16
Top Buys
| 1 |
Cigna
CI
|
$12M |
| 2 |
Aldeyra Therapeutics
ALDX
|
$9.27M |
| 3 |
Pfizer
PFE
|
$7.94M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.16M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$6.1M |
Top Sells
| 1 |
Baxter International
BAX
|
$26.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
$24.7M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
$14.6M |
| 4 |
Johnson & Johnson
JNJ
|
$13.7M |
| 5 |
Humana
HUM
|
$10.8M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
